Blackhawk Provides Corporate Update

Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$432/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Return to homepage

(TheNewswire)



Vancouver, British Columbia – TheNewswire - September 14, 2020 – Blackhawk Growth Corp. (CSE:BLR) (CNSX:BLR.CN) (OTC:BLRZF) (the “Corporation” or “Blackhawk”), is pleased to provide the following corporate updates. As of September 3rd, 2020, it has received a signed letter of authorization confirming that Blackhawk is the sole entity that possesses non-exclusive rights to distribute the SARS-CoV-2 IgG/IgM Rapid Test Kit as well as the ExProbe SARS-CoV-2 Test Kit. The letter has been posted on Blackhawk’s website.

Sales and distribution of the test kits has commenced. Negotiations have begun with a First Nations group in California and the Corporation’s sales teams have been approached by several private sector groups and laboratories that have expressed interest in large purchase orders.  Blackhawk has also been able to provide all laboratory equipment necessary for PCR testing. This has provided a distinct advantage that the sales teams will be able to leverage.

The NuWave team was in Delta, British Columbia the week of September 7th looking to expand on its food stabilization capacity. There has been significant interest from large retail chains and the team at NuWave must be able to accommodate demand before entering into any commitments.  Blackhawk expects to have updates on the results of these meetings and the anticipated launch of NuWave products shortly.

“We are rapidly moving towards the finish line on multiple fronts” said Frederick Pels, CEO of Blackhawk. “We have an exceptional and needed Covid-19 testing solution that covers rapid testing, PCR testing and the lab equipment itself. We are working tirelessly to get these test kits in the hands of large laboratories and private sector groups, and we look forward to sharing our progress with our shareholders in due course.  In addition, NuWave has a fantastic product that I expect to see available in stores very soon. Our partnership with Specialty D Baking has been tremendous and has gotten us in front of some of the largest grocery chains in Canada. I am confident that once NuWave is able to showcase the suite of products and increase capacity, NuWave could become a much needed household staple. Preservative free, shelf stable food is an innovation that is highly in demand and NuWave is on track to become a leader in this industry.”

 

For further information please contact:

Frederick Pels, Chief Executive Officer

(403)-991-7737

[email protected]

Cautionary Note Regarding Forward-Looking Statement

 

All statements in this press release, other than statements of historical fact, are “forward-looking information” with respect to the Corporation within the meaning of applicable securities laws, including with respect to the marketing and distribution of test kits in North and South America, and anticipated demand for products produced by NuWave. The Corporation provides forward-looking statements for the purpose of conveying information about current expectations and plans relating to the future and readers are cautioned that such statements may not be appropriate for other purposes. By its nature, this information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achieved. These risks and uncertainties include but are not limited those identified and reported in the Corporation’s public filings under the Corporation’s SEDAR profile at www.sedar.com. Although the Corporation has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking information, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements. The Corporation disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise unless required by law.

Copyright (c) 2020 TheNewswire - All rights reserved.